spacer
home > pmps > autumn 2018 > broadening biologics
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Broadening Biologics

In recent years, the pharmaceutical industry has seen a steady shift toward increased patient centricity. The impact can be seen in nearly every aspect of the industry – from regulatory guidance, trial design, and drug delivery to new drugs proliferating the pipeline, such as biologics.

Biologics are used to treat chronic conditions, such as multiple sclerosis and other autoimmune diseases. Additionally, by targeting specific components of a disease in ways never thought possible before, these therapies also may help some acute conditions, including certain types of cancer, become manageable chronic conditions.

Biologics are set to experience rapid and transformative growth over the next several years as more drug manufacturers tap into their potential. They are already outpacing the compound annual growth rate of the wider pharma industry, mainly driven by the US (1). Most global spending growth, particularly in developed markets, will be driven by oncology, autoimmune, and diabetes treatments where significant innovations are expected. Industry forecasts predict the global annual spend for autoimmune diseases alone to be US $75-90 billion in 2021 (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Victoria Morgan has been in the pharma industry for 25 years with extensive experience in the area of injection drug delivery products, such as primary packaging and combination products for vial, cartridge, and pre-filled syringe systems. Throughout her tenure at West Pharmaceutical Services, Inc, she has served in various functions across sales and marketing. Victoria spent more than 17 years in global sales roles, with her most recent position being Director of Segment Marketing for Biologics, where she has responsibility for global biologic strategy development and implementation.
spacer
Victoria Morgan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Bottling Line Expansion to Support Customer Needs

Philadelphia, USA – February 5, 2019 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global biopharmaceutical industry, is pleased to announce the expansion of its bottling line capacity at its Commercial Packaging site in Rockford, IL. Construction of the additional packaging suites began in March 2018 to add considerable footprint for primary and secondary packaging operations equipped with high speed tablet filling, cartoning, as well as in-line serialization and aggregation in support of increased customer demand. The new expansion will grow the robust bottling operation in Rockford by producing an extra 100 million bottles per year.
More info >>

White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement